Insiders · CUE

CUE insider transactions

Cue Biopharma Inc. (CUE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CUE

• 2d
  Chief Medical Officer Borie Dominique Christian was granted 31,500 shares (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 2d
  SEC Form 3 filed by new insider Borie Dominique Christian

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 7d
  Director Garzone Pamela was granted 21,800 shares (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 7d
  Director Camardo Daniel A. was granted 21,800 shares (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 7d
  Director Sarraf Pasha was granted 21,800 shares, increasing direct ownership by 202% to 32,595 units (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 7d
  Director Meehan Viola Mong was granted 21,800 shares (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 7d
  VP, Prin. Accounting Officer Meluzio Michael Vincent was granted 40,942 shares (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 7d
  Chief Legal Compliance Officer Ray Sumita was granted 54,589 shares, increasing direct ownership by 100% to 109,178 units (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 7d
  Chief Executive Officer Lin Shao-Lee was granted 327,537 shares, increasing direct ownership by 100% to 655,074 units (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 36d
  SEC Form 3 filed by new insider Meluzio Michael Vincent

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 36d
  New insider Ray Sumita claimed ownership of 54,589 shares (SEC Form 3)

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 39d
  SEC Form 4 filed by Director Camardo Daniel A.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 39d
  SEC Form 3 filed by new insider Camardo Daniel A.

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 44d
  SEC Form 4 filed by Chief Executive Officer Lin Shao-Lee

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 45d
  SEC Form 4 filed by Director Meehan Viola Mong

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 45d
  SEC Form 3 filed by new insider Meehan Viola Mong

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 71d
  SEC Form 3 filed by new insider Lin Shao-Lee

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 71d
  CHIEF EXECUTIVE OFFICER Lin Shao-Lee was granted 327,537 shares (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 98d
  SEC Form 4 filed by Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 98d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 98d
  SEC Form 4 filed by Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 192d
  SEC Form 4 filed by Director Broadfoot Jill Marie

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 192d
  SEC Form 4 filed by Director Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 192d
  SEC Form 4 filed by Director Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 192d
  SEC Form 4 filed by Director Sarraf Pasha

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 192d
  SEC Form 4 filed by Director Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 192d
  SEC Form 4 filed by Director Morich Frank

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 196d
  Director Sarraf Pasha bought $99,747 worth of shares (323,857 units at $0.31) (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 224d
  SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 234d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 234d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 288d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Azam Usman

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 288d
  SEC Form 3 filed by new insider Azam Usman

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 406d
  SEC Form 4 filed by Director Broadfoot Jill Marie

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 406d
  SEC Form 3 filed by new insider Broadfoot Jill Marie

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 479d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 479d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 479d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Passeri Daniel R

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 479d
  SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 479d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 479d
  SEC Form 4 filed by Chief Medical Officer Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 492d
  SEC Form 3 filed by new insider Sarraf Pasha

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 492d
  SEC Form 4 filed by Director Sarraf Pasha

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 560d
  SEC Form 4 filed by Director Morich Frank

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 560d
  SEC Form 4 filed by Director Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 560d
  SEC Form 4 filed by Director Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 560d
  SEC Form 4 filed by Director Driscoll Frederick W

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 560d
  SEC Form 4 filed by Director Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 576d
  CHIEF EXECUTIVE OFFICER Passeri Daniel R bought $30,900 worth of shares (30,000 units at $1.03), increasing direct ownership by 22% to 164,578 units (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 595d
  SEC Form 3 filed by new insider Baker Daniel G.

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 595d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 680d
  SEC Form 3 filed by new insider Warren Lucinda

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 680d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 770d
  SEC Form 4 filed by Fox Michael J

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 770d
  SEC Form 4 filed by Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 770d
  SEC Form 4 filed by Suri Anish

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 770d
  New insider Fox Michael J claimed ownership of 1,100,000 shares (SEC Form 3)

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 770d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 770d
  SEC Form 4 filed by Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 861d
  SEC Form 4 filed by Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)